Mindmed to present at the h.c. wainwright 5th annual neuro perspectives virtual conference

New york--(business wire)---- $mnmd--mind medicine (mindmed) inc. (nasdaq: mnmd) (the “company” or “mindmed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that members of the company's management team will present at the h.c. wainwright 5th annual neuro perspectives virtual conference being held on june 27, 2024. a webcast of the fireside chat will be accessible on mindmed's investor relations website starting on june 27,.
MNMD Ratings Summary
MNMD Quant Ranking